Overview

A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study Participants

Status:
Not yet recruiting

Trial end date:
2022-05-30

Target enrollment:

Participant gender:

Summary

The purpose of the study is to demonstrate the bioequivalence between the BRV tablet and BRV as dry syrup after a single oral dose in healthy Japanese male study participants.

Phase:

Phase 1

Details

Lead Sponsor:

UCB Biopharma SRL

Treatments:

Brivaracetam